6,500,000 Shares ARATANA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2014 • Avalon Ventures IX GP, LLC • Pharmaceutical preparations • New York
SERIES C PREFERRED STOCK PURCHASE AGREEMENTSeries C Preferred Stock Purchase Agreement • July 8th, 2013 • Avalon Ventures IX GP, LLC • Pharmaceutical preparations • Delaware
THIS SERIES C PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 28, 2012, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).
SERIES B PREFERRED STOCK PURCHASE AGREEMENTSeries B Preferred Stock Purchase Agreement • July 8th, 2013 • Avalon Ventures IX GP, LLC • Pharmaceutical preparations • Delaware
THIS SERIES B PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 1, 2011, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).
SERIES A PREFERRED STOCK PURCHASE AGREEMENTSeries a Preferred Stock Purchase Agreement • July 8th, 2013 • Avalon Ventures IX GP, LLC • Pharmaceutical preparations • Delaware
THIS SERIES A PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 27, 2010, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).
Exhibit A Joint Filing Agreement Pursuant to Rule 13d-1Joint Filing Agreement • July 8th, 2013 • Avalon Ventures IX GP, LLC • Pharmaceutical preparations
This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the “Act”) by and among the parties listed below, each referenced to herein as a “Joint Filer.” The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.
LOCK-UP AGREEMENTLock-Up Agreement • July 8th, 2013 • Avalon Ventures IX GP, LLC • Pharmaceutical preparations • New York
